FIORICET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fioricet, and what generic alternatives are available?
Fioricet is a drug marketed by Actavis Labs Ut Inc and is included in one NDA.
The generic ingredient in FIORICET is acetaminophen; butalbital; caffeine; codeine phosphate. There are sixty-six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine; codeine phosphate profile page.
Summary for FIORICET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FIORICET |
DailyMed Link: | FIORICET at DailyMed |
Recent Clinical Trials for FIORICET
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
GlaxoSmithKline | Phase 3 |
US Patents and Regulatory Information for FIORICET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | FIORICET W/ CODEINE | acetaminophen; butalbital; caffeine; codeine phosphate | CAPSULE;ORAL | 020232-001 | Jul 30, 1992 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |